XLO: Xilio Therapeutics, Inc. Stock

by  •  • Comments Off on XLO: Xilio Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 39.87
Enterprise Value ($M) 9.20
Book Value ($M) 25.77
Book Value / Share 0.70
Price / Book 1.55
NCAV ($M) 12.34
NCAV / Share 0.33
Price / NCAV 3.23

Profitability (mra)
Return on Invested Capital (ROIC) -1.86
Return on Assets (ROA) -0.64
Return on Equity (ROE) -0.84

Liquidity (mrq)
Quick Ratio 2.19
Current Ratio 2.19

Balance Sheet (mrq) ($M)
Current Assets 69.19
Assets 82.61
Liabilities 56.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -79.13
Net Income -76.40
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -68.62
Cash from Investing -0.49
Cash from Financing -6.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A Rock Springs Capital Management LP 8.71 108.45
04-05 13G Gilead Sciences Inc 19.90
02-06 13G/A Octagon Capital Advisors LP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-11-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-11-09 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 27,924 105,571 26.45
2024-05-16 64,551 221,407 29.15
2024-05-15 16,721 38,389 43.56
2024-05-14 18,210 11,931 152.63
2024-05-13 51,114 273,985 18.66

(click for more detail)

Similar Companies
VYGR – Voyager Therapeutics, Inc. XBIT – XBiotech Inc.
XERS – Xeris Biopharma Holdings, Inc. YMAB – Y-mAbs Therapeutics, Inc.
ZVRA – Zevra Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io